ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 13 Jul 2015
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
86154405 filed on 30th Dec 2013
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EVNELO
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 86154405
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Jul 2015 | ABANDONMENT - NO USE STATEMENT FILED |
| 13th Jul 2015 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 09th Dec 2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 14th Oct 2014 | PUBLISHED FOR OPPOSITION |
| 14th Oct 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Sep 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Sep 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 11th Sep 2014 | ASSIGNED TO LIE |
| 29th Aug 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 28th Aug 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |